Literature DB >> 4567305

Negamycin, a miscoding antibiotic with a unique structure.

Y Uehara, S Kondo, H Umezawa, K Suzukake, M Hori.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1972        PMID: 4567305     DOI: 10.7164/antibiotics.25.685

Source DB:  PubMed          Journal:  J Antibiot (Tokyo)        ISSN: 0021-8820            Impact factor:   2.649


× No keyword cloud information.
  6 in total

1.  Negamycin induces translational stalling and miscoding by binding to the small subunit head domain of the Escherichia coli ribosome.

Authors:  Nelson B Olivier; Roger B Altman; Jonas Noeske; Gregory S Basarab; Erin Code; Andrew D Ferguson; Ning Gao; Jian Huang; Manuel F Juette; Stephania Livchak; Matthew D Miller; D Bryan Prince; Jamie H D Cate; Ed T Buurman; Scott C Blanchard
Journal:  Proc Natl Acad Sci U S A       Date:  2014-11-03       Impact factor: 11.205

2.  Negamycin binds to the wall of the nascent chain exit tunnel of the 50S ribosomal subunit.

Authors:  Susan J Schroeder; Gregor Blaha; Peter B Moore
Journal:  Antimicrob Agents Chemother       Date:  2007-07-30       Impact factor: 5.191

3.  Ribosomal function and its inhibition by antibiotics in prokaryotes.

Authors:  K H Nierhaus; H G Wittmann
Journal:  Naturwissenschaften       Date:  1980-05

4.  Actual new cancer-causing hydrazines, hydrazides, and hydrazones.

Authors:  B Toth
Journal:  J Cancer Res Clin Oncol       Date:  1980       Impact factor: 4.553

5.  The Antibiotic Negamycin Crosses the Bacterial Cytoplasmic Membrane by Multiple Routes.

Authors:  Daniel Hörömpöli; Catherine Ciglia; Karl-Heinz Glüsenkamp; Lars Ole Haustedt; Hildegard Falkenstein-Paul; Gerd Bendas; Anne Berscheid; Heike Brötz-Oesterhelt
Journal:  Antimicrob Agents Chemother       Date:  2021-03-18       Impact factor: 5.191

6.  Negamycin interferes with decoding and translocation by simultaneous interaction with rRNA and tRNA.

Authors:  Yury S Polikanov; Teresa Szal; Fuyan Jiang; Pulkit Gupta; Ryoichi Matsuda; Masataka Shiozuka; Thomas A Steitz; Nora Vázquez-Laslop; Alexander S Mankin
Journal:  Mol Cell       Date:  2014-10-09       Impact factor: 17.970

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.